Innate Pharma S.A. (EPA:IPH)
1.672
-0.008 (-0.48%)
At close: Dec 5, 2025
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €154.10 million as of December 5, 2025. Its market cap has increased by 32.94% in one year.
Market Cap
154.10M
Enterprise Value
121.11M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.67
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 154.10M, an increase of 19,354.51%. That is a compound annual growth rate of 31.77%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 139.82B |
| Sanofi | 102.91B |
| Sartorius Stedim Biotech | 20.82B |
| bioMérieux | 12.30B |
| Eurofins Scientific SE | 10.46B |
| Ipsen | 10.05B |
| ABIVAX Société Anonyme | 7.05B |
| Virbac | 2.99B |